Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China
PurposeCarbapenem-resistant Klebsiella pneumoniae (CRKP) producing carbapenemases poses a global threat to public health. Antimicrobial agent combinations have been promoted as a potential therapeutic strategy for infections. The most effective antimicrobial combinations against CRKP strains produci...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2024.1519319/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832591673643761664 |
---|---|
author | Congcong Liu Congcong Liu Yuchen Wu Yanyan Zhang Zelin Yan Danxia Gu Danxia Gu Hongwei Zhou Ning Dong Chang Cai Gongxiang Chen Rong Zhang |
author_facet | Congcong Liu Congcong Liu Yuchen Wu Yanyan Zhang Zelin Yan Danxia Gu Danxia Gu Hongwei Zhou Ning Dong Chang Cai Gongxiang Chen Rong Zhang |
author_sort | Congcong Liu |
collection | DOAJ |
description | PurposeCarbapenem-resistant Klebsiella pneumoniae (CRKP) producing carbapenemases poses a global threat to public health. Antimicrobial agent combinations have been promoted as a potential therapeutic strategy for infections. The most effective antimicrobial combinations against CRKP strains producing different carbapenemases are currently unclear, particularly those producing the KPC variant carbapenemases. This study is aimed to evaluate the effectiveness of various antimicrobial agent combinations against CRKP strains with different carbapenemases.MethodsA checkerboard assay involving 24 antimicrobial agent combinations was conducted on 44 strains of carbapenemase-producing CRKP isolated from patients of which 13 CRKP strains carried single KPC variants. The 24 antimicrobial combinations were based on meropenem, polymyxin, tigecycline, ceftazidime/avibactam, respectively. The fractional inhibitory concentration (FIC) indexes were calculated for each combination of antimicrobial agents.ResultsThe distribution of carbapenemases in 44 CRKP strains was as follows: KPC variants (n = 13, 29.5%), KPC-2 (n = 10, 22.7%), metallo-β-lactamases (n = 9, 20.5%), OXA-48-like (n = 12, 27.3%). In the checkerboard assay, the combination of polymyxin and aztreonam exhibited the highest synergistic effect against CRKP strains, with a rate of 95.5% (42/44). This was followed by polymyxin-meropenem at 88.6% (39/44) and polymyxin-levofloxacin at 68.2% (30/44). Additionally, polymyxin-aztreonam combination and polymyxin-meropenem showed the highest sum of synergistic and additive rates of 100.0% against KPC variant-producing CRKP strains. Notably, ceftazidime/avibactam-based combinations exhibited better synergistic effects on KPC variant-producing CRKP strains compared to other CRKP strains with adjusted p value <0.05.ConclusionOur study suggests that the combinations of antimicrobial agent could serve as potential treatment strategies against CRKP infections. Furthermore, the effectiveness of these combinations is influenced by the types of carbapenemases present. Ceftazidime/avibactam-based combinations have showed superior synergistic effects on KPC variant-producing CRKP strains. |
format | Article |
id | doaj-art-07f9d96f7e934d9cb91b0a4563308849 |
institution | Kabale University |
issn | 1664-302X |
language | English |
publishDate | 2025-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Microbiology |
spelling | doaj-art-07f9d96f7e934d9cb91b0a45633088492025-01-22T07:11:32ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2025-01-011510.3389/fmicb.2024.15193191519319Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in ChinaCongcong Liu0Congcong Liu1Yuchen Wu2Yanyan Zhang3Zelin Yan4Danxia Gu5Danxia Gu6Hongwei Zhou7Ning Dong8Chang Cai9Gongxiang Chen10Rong Zhang11Department of Clinical Laboratory, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Clinical Laboratory, Zhejiang Provincial People's Hospital, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaMOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Key Laboratory of Pathogen Bioscience and Anti-infective Medicine, School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, ChinaCollege of Animal Science and Technology, College of Veterinary Medicine, Zhejiang Agricultural and Forestry University, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaDepartment of Clinical Laboratory, Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, ChinaPurposeCarbapenem-resistant Klebsiella pneumoniae (CRKP) producing carbapenemases poses a global threat to public health. Antimicrobial agent combinations have been promoted as a potential therapeutic strategy for infections. The most effective antimicrobial combinations against CRKP strains producing different carbapenemases are currently unclear, particularly those producing the KPC variant carbapenemases. This study is aimed to evaluate the effectiveness of various antimicrobial agent combinations against CRKP strains with different carbapenemases.MethodsA checkerboard assay involving 24 antimicrobial agent combinations was conducted on 44 strains of carbapenemase-producing CRKP isolated from patients of which 13 CRKP strains carried single KPC variants. The 24 antimicrobial combinations were based on meropenem, polymyxin, tigecycline, ceftazidime/avibactam, respectively. The fractional inhibitory concentration (FIC) indexes were calculated for each combination of antimicrobial agents.ResultsThe distribution of carbapenemases in 44 CRKP strains was as follows: KPC variants (n = 13, 29.5%), KPC-2 (n = 10, 22.7%), metallo-β-lactamases (n = 9, 20.5%), OXA-48-like (n = 12, 27.3%). In the checkerboard assay, the combination of polymyxin and aztreonam exhibited the highest synergistic effect against CRKP strains, with a rate of 95.5% (42/44). This was followed by polymyxin-meropenem at 88.6% (39/44) and polymyxin-levofloxacin at 68.2% (30/44). Additionally, polymyxin-aztreonam combination and polymyxin-meropenem showed the highest sum of synergistic and additive rates of 100.0% against KPC variant-producing CRKP strains. Notably, ceftazidime/avibactam-based combinations exhibited better synergistic effects on KPC variant-producing CRKP strains compared to other CRKP strains with adjusted p value <0.05.ConclusionOur study suggests that the combinations of antimicrobial agent could serve as potential treatment strategies against CRKP infections. Furthermore, the effectiveness of these combinations is influenced by the types of carbapenemases present. Ceftazidime/avibactam-based combinations have showed superior synergistic effects on KPC variant-producing CRKP strains.https://www.frontiersin.org/articles/10.3389/fmicb.2024.1519319/fullcarbapenem-resistant Klebsiella pneumoniaecheckerboard assayantimicrobial agent combinationsKPC variantceftazidime/avibactam-based dual combinations |
spellingShingle | Congcong Liu Congcong Liu Yuchen Wu Yanyan Zhang Zelin Yan Danxia Gu Danxia Gu Hongwei Zhou Ning Dong Chang Cai Gongxiang Chen Rong Zhang Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China Frontiers in Microbiology carbapenem-resistant Klebsiella pneumoniae checkerboard assay antimicrobial agent combinations KPC variant ceftazidime/avibactam-based dual combinations |
title | Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China |
title_full | Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China |
title_fullStr | Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China |
title_full_unstemmed | Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China |
title_short | Effectiveness of antimicrobial agent combinations against carbapenem-producing Klebsiella pneumoniae with KPC variants in China |
title_sort | effectiveness of antimicrobial agent combinations against carbapenem producing klebsiella pneumoniae with kpc variants in china |
topic | carbapenem-resistant Klebsiella pneumoniae checkerboard assay antimicrobial agent combinations KPC variant ceftazidime/avibactam-based dual combinations |
url | https://www.frontiersin.org/articles/10.3389/fmicb.2024.1519319/full |
work_keys_str_mv | AT congcongliu effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina AT congcongliu effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina AT yuchenwu effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina AT yanyanzhang effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina AT zelinyan effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina AT danxiagu effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina AT danxiagu effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina AT hongweizhou effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina AT ningdong effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina AT changcai effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina AT gongxiangchen effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina AT rongzhang effectivenessofantimicrobialagentcombinationsagainstcarbapenemproducingklebsiellapneumoniaewithkpcvariantsinchina |